Evidence map›Paper›PMID 32582980›Full record

ArticleInternational journal of molecular medicine2020

Mutated SASH1 promotes Mitf expression in a heterozygous mutated SASH1 knock‑in mouse model.

Zexi Xu, Yadong Li, Dahong Wang, Daoqiu Wu, Jinyun Wang, Lian Chen, Yinqian Deng, Jing Zhang, Zhixiong Wu, Xin Wan and 5 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 13 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Zexi XuClinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Yadong LiClinical College, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Dahong WangClinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Daoqiu WuSchool of Clinical Laboratory Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Jinyun WangSchool of Biology and Engineering, Guizhou Medical University, Guiyang, Guizhou 550025, P.R. China.
Lian ChenClinical College, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Yinqian DengClinical College, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Jing ZhangClinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Zhixiong WuClinical College, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Xin WanClinical College, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Qianfan LiuClinical College, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Hai HuangSchool of Clinical Laboratory Sciences, Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Pingsheng HuClinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Jiawei ZengDepartment of Clinical Laboratory, Mianyang Central Hospital, Mianyang, Sichuan 621000, P.R. China.
Ding'an ZhouClinical Research Center, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Guiyang Medical University · CNAffiliated Hospital of Guizhou Medical University · CNMianyang Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SAM and SH3 domain‑containing 1 (SASH1) genes have been identified as the causal genes of dyschromatosis universalis hereditaria (DUH); these genes cause the pathological phenotypes of DUH, and SASH1 variants have been shown to regulate the abnormal pigmentation phenotype in human skin in various genodermatoses. However, investigations into the mutated SASH1 gene have been limited to in vitro studies. In the present study, to recapitulate the molecular pathological phenotypes of individuals with DUH induced by SASH1 mutations, a heterozygous BALB/c mouse model, in which the human SASH1 c.1654 T>G (p. Tyr 551Asp, Y551D) mutation was knocked in was first generated. The in vivo functional experiments on Y551D SASH1 indicated that the increased expression of microphthalmia‑associated transcription factor (Mitf) was uniformly induced in the tails of heterozygous BALB/c mice, and an increased quantity of Mitf‑positive epithelial cells was also detected. An increased expression of Mitf‑ and Mitf‑positive cells was also demonstrated in the epithelial tissues of Y551D‑SASH1 affected individuals. In the present study, Mitf expression was also found to be increased by Y551D SASH1 in vitro. Taken together, these findings indicate that the upregulation of Mitf is the bona fide effector of the Y551D SASH1‑mediated melanogenesis signaling pathway in vivo. SASH1 may function as a scaffold molecule for the assembly of a SASH1‑Mitf molecular complex to regulate Mitf expression in the cell nucleus and thus to promote the hyperpigmented phenotype in the pathogenesis of DUH and other genodermatoses related to pigment abnormalities.

Indexed as

AnimalsCell NucleusFemaleHeterozygoteHumansMaleMiceMice, Inbred BALB CMicrophthalmia-Associated Transcription FactorMutationPedigreePigmentation DisordersProtein BindingRNA, MessengerSignal TransductionSkin Diseases, GeneticMicrophthalmia-Associated Transcription FactorMitf protein, mouseRNA, MessengerSash1 protein, mouseTumor Suppressor Proteins

Identifiers

PMID32582980
PMCPMC7387086
OpenAlexW3036202319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.